Articles |
 Page 1 of 7  |
Curious and confused: Prescription drug ads impact consumer health.
October 27, 2003
|
Canada drug company opens doors to governors, mayors.
October 27, 2003
|
Results from preclinical study of Ilomastat presented.
October 27, 2003
|
Ohio contract research organization opens Munich office.
October 27, 2003
|
$4M to $7M budgets help business development teams win alliances.
October 27, 2003
|
Anti-infectives drug firm raises UKP 25M.
October 27, 2003
|
Biotech company's chairman adopts Rule 10b5-1 trading plan.
October 27, 2003
|
Cancer-screening company's shares relisted on OTC bulletin board.
October 27, 2003
|
Cardiovascular drug maker reports decreased revenues.
October 27, 2003
|
Dental pharmaceuticals company to sell 2M shares of common stock.
October 27, 2003
|
Exercise of over-allotment option valued at approximately US$33M.
October 27, 2003
|
Hormone therapy company commences trading on AMEX.
October 27, 2003
|
Microarray company to trade on Amex.
October 27, 2003
|
Pharmaceutical firm announces $41M direct equity placement.
October 27, 2003
|
Pharmaceutical firm announces revised exchange offer.
October 27, 2003
|
Pharmaceutical firm's resale registration statement declared effective...
October 27, 2003
|
Public offering reported by diabetes drug maker.
October 27, 2003
|
SEC declares oncology company's resale registration statement effectiv...
October 27, 2003
|
Wellbutrin maker provides guidance on third quarter 2003 results.
October 27, 2003
|
Biotechnology company raises $11.5M in private placement.
October 27, 2003
|
Drug discovery company receives $300K in grants.
October 27, 2003
|
Pharmaceutical company receives tentative approval to manufacture new ...
October 27, 2003
|
Drug makers hope to profit from WTO decision on medications.
October 27, 2003
|
Invitrogen enters agreement to optimize gene-expression analysis.
October 27, 2003
|
$10M in milestone funding to be used for HIV fusion inhibitor.
October 27, 2003
|
$16.7M NIH contract to develop HIV vaccine.
October 27, 2003
|
Preclinical testing of second generation HIV viral entry inhibitor exp...
October 27, 2003
|
Biopharmaceutical company awarded $19M contract to develop HIV vaccine...
October 27, 2003
|
Pharmaceutical company awarded contract to develop HIV vaccine.
October 27, 2003
|
Phase II study of Remune with HIV-infected patients begins in Italy.
October 27, 2003
|
Blue Care Network of Michigan will cover Prilosec, Claritin.
October 27, 2003
|
European approval of Remodulin delayed.
October 27, 2003
|
Agreement signed for access to eTag assay system.
October 27, 2003
|
After rough period, biotech industry on upswing in New Jersey, Pennsyl...
October 27, 2003
|
CDC partners with University of Liverpool for research alliance.
October 27, 2003
|
FDA panel issues favorable recommendation for Luveris in follicular de...
October 27, 2003
|
MDS signs global-technology outsourcing agreement.
October 27, 2003
|
Software helps reduce medication errors.
October 27, 2003
|
Company to discontinue U.S. development of dexloxiglumide.
October 27, 2003
|
Six professionals awarded $50K each in support of kidney disease resea...
October 27, 2003
|
FDA clearance granted to market InstaRead rapid test for psychiatric u...
October 27, 2003
|
FDA special protocol assessment review for Telcyta completed.
October 27, 2003
|
Immunological data from phase II cancer trials of vaccine published.
October 27, 2003
|
American Capital invests $49M in buyout of radiation dosimetry service...
October 27, 2003
|
Gene Logic announces postacquisition integration and market-alignment ...
October 27, 2003
|
Genesis Bioventures, Inc., provides merger update.
October 27, 2003
|
Hycor files registration statement on Form S-4.
October 27, 2003
|
IsoTis merger almost complete.
October 27, 2003
|
Kendle completes acquisition of Mexican contract-research organization...
October 27, 2003
|
Letter of intent signed to acquire Plan B.
October 27, 2003
|
FDA approves new Zomig (zolmitriptan) nasal spray formulation.
October 27, 2003
|
Sumatriptan succinate tablets effective in treating menstrual migraine...
October 27, 2003
|
Licensing rights to Fampridine-SR expanded.
October 27, 2003
|
Phase II/III clinical development program initiated for anti-cancer ag...
October 27, 2003
|
Oral salmon calcitonin phase IIa data presented.
October 27, 2003
|
Progress report provided on the development of ENT-103.
October 27, 2003
|
New U.S. patent issued for vascular targeting agents.
October 27, 2003
|
Through-hole array intellectual property portfolio purchased.
October 27, 2003
|
U.S. patent granted for bifunctional compounds.
October 27, 2003
|
Clinical trials management company appoints new chief executive office...
October 27, 2003
|
Noonan named to board of directors at devic firm.
October 27, 2003
|
Paterson joins pharmaceutical firm.
October 27, 2003
|
Starr named to board of directors at RNA company.
October 27, 2003
|
VP of business development named at pharmaceutical firm.
October 27, 2003
|
Vice chairman, president named at biotech company.
October 27, 2003
|
Warthen named VP of sales, business development at lab IT company.
October 27, 2003
|
FDA accepted DepoMorphine NDA for filing.
October 27, 2003
|
Pin1 enzyme shown to predict severity of prostate cancer.
October 27, 2003
|
Fumaderm - oral psoriasis therapy - licensed from Fumapharm.
October 27, 2003
|
Remodulin study data show reductions in mean pulmonary arterial pressu...
October 27, 2003
|
Intellectual property, expertise reported in hepatitis research.
October 27, 2003
|
Milestone achieved with filing of IND application for Numax.
October 27, 2003
|
Beneficial effects of antibodies to interferon-gamma presented.
October 27, 2003
|
Company launches shortage product for early-stage rheumatoid arthritis...
October 27, 2003
|
Contract awarded from NIH for development of SARS vaccine.
October 27, 2003
|
| |
1
